Terms: = Lung cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Diagnosis
6 results:
1. Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
Dalvi T; Nørgaard M; Fryzek JP; Movva N; Pedersen L; Pham Hansen H; Walker J; Midha A; Shire N; Boothman AM; Rigas J; Mellemgaard A; Rasmussen TR; Hamilton-Dutoit S; Cronin-Fenton D
PLoS One; 2023; 18(4):e0284037. PubMed ID: 37040387
[TBL] [Abstract] [Full Text] [Related]
2. CircSRSF4 Enhances Proliferation, Invasion, and Migration to Promote the Progression of Osteosarcoma via rac1.
Sun X; Zhao X; Xu S; Zhou Y; Jia Z; Li Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682879
[TBL] [Abstract] [Full Text] [Related]
3. IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the rac1/NF-κB/MMP2 signal pathway.
Wang X; Wei Z; Tang Z; Xue C; Yu H; Zhang D; Li Y; Liu X; Shi Y; Zhang L; Chen G; Zhou H; Wang J; Wang X
Lab Invest; 2021 Jun; 101(6):760-774. PubMed ID: 33753880
[TBL] [Abstract] [Full Text] [Related]
4. MiR-135a inhibits non-small cell lung cancer progression by suppressing RAB1B expression and the RAS pathway.
Tian Y; Zhang L; Yu Q; Wang Z; Yang X
Aging (Albany NY); 2020 Jul; 12(14):14480-14489. PubMed ID: 32710726
[TBL] [Abstract] [Full Text] [Related]
5. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting rac1 activation and VEGF expression.
Li Z; Guo C; Liu X; Zhou C; Zhu F; Wang X; Wang Q; Shi Y; Wang J; Zhao W; Zhang L
Oncotarget; 2016 Sep; 7(38):62224-62239. PubMed ID: 27556698
[TBL] [Abstract] [Full Text] [Related]
6. Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific.
Woolston A; Sintupisut N; Lu TP; Lai LC; Tsai MH; Chuang EY; Yeang CH
Oncotarget; 2015 Aug; 6(23):19483-99. PubMed ID: 26160836
[TBL] [Abstract] [Full Text] [Related]
